Skip to content

Abstract C109: Longitudinal depressive symptom burden during early survivorship among survivors of young adult cancer

Oct 2026 · Cancer Epidemiology, Biomarkers & Prevention · 0 citations

Abstract

To characterize depressive symptom trajectories among ethnically diverse survivors of young adult cancer during the first year following a de novo cancer diagnosis and identify sociodemographic and clinical factors associated with longitudinal depressive symptom severity. Young adults aged 18-39 years were recruited within 3 months of a de novo cancer diagnosis from two comprehensive cancer centers and a safety-net hospital, representing all cancer stages. Baseline questionnaire captured self-reported sociodemographic and clinical characteristics. Depressive symptoms were measured using the 8-item Center for Epidemiologic Studies Depression Scale (CES-D-8) at four time points (baseline, 3-, 6-, and 12-months from baseline). Scores ranged from 0-3; clinically meaningful depressive symptoms were defined as a score ≥ 7. A linear mixed-effects model (LMM) was used to evaluate changes in depressive symptom severity over time and identify sociodemographic and clinical predictors of longitudinal symptom burden. Covariates included ages at diagnosis, gender, Hispanic/Latino ethnicity, household income, educational attainment, insurance status, and cancer stage at diagnosis. Among 176 survivors of young adult cancer, the mean age at diagnosis was 32.2 years (SD=5.50). Approximately half identified as Hispanic/Latino (56.3%), 66.5% were female, 44.9% had an annual household income of <$40k, 44.5% had a college degree or higher, 46% were diagnosed with stage I cancer. The LMM demonstrated clinically elevated depressive symptom burden at baseline (β=10.388; 95% CI: 9.339, 11.437; p<.001). Mean CES-D-8 scores exceeded the clinical threshold for depressive symptoms at subsequent time points (3-months=10.2; 6- months=10.1; 12-months=9.8). Depressive symptom severity declined modestly during follow-up, with CES-D-8 scores decreasing by an average of 0.071 points per month (β=-0.071; 95% CI: -0.126, -0.017; p=.010). Compared with participants with a household income of ≥$80,000, those with incomes of $40,000-$79,000 demonstrated higher depressive symptom severity, but this difference was not significant (β=1.388; 95% CI: 0.004, 2.767; p=.052). No other sociodemographic or clinical characteristics were significantly associated with depressive symptom severity. Throughout the first year after diagnosis, survivors of young adult cancer experienced elevated depressive symptoms with modest improvements over time, highlighting a sustained need for additional psychosocial support during early survivorship. These findings support routine longitudinal depression screening and timely referral to psychosocial services, with particular attention to survivors facing financial vulnerability, for whom age and household income may compound disparities in mental health outcomes. Larger longitudinal studies are needed to inform the development of interventions targeting depressive symptoms during the transition from diagnosis to survivorship. Mariah B. Echeverria, Julia Stal, Dayanara Ruiz, Maureen Cairns, Priscilla Marin, Jonathan N. Kaslander, Kimberly A. Miller. Longitudinal depressive symptom burden during early survivorship among survivors of young adult cancer [abstract]. In: Proceedings of the 19th AACR Conference on the Science of Cancer Health Disparities; 2026 Oct 18-21; Atlanta, GA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2026;35(10 Suppl):Abstract nr C109.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.